SEOUL, South Korea, Jan. 13 /PRNewswire/ -- AstraZeneca and CrystalGenomics (KOSDAQ: CRYSTAL [A083790]) announced today that they have entered into a research collaboration to discover and develop a novel anti-infective for use as a potential antibacterial agent.
Under the terms of this agreement, K